| ALK | Anaplastic lymphoma kinase |
| ANOVA | Analysis of variance |
| BBB | Blood-brain barrier |
| BM | Brain metastases |
| EGFR | Epidermal growth factor receptor |
| ICIs | Immune checkpoint inhibitors |
| KPS | Karnofsky performance scale |
| mOS | Median overall survival |
| NA | Not available |
| OS | Overall survival |
| PD-1 | Programmed cell death 1 |
| PD-L1 | Programmed death-ligand 1 |
| RET | Rearranged during Transfection |
| ROS1 | c-ros oncogene 1, receptor tyrosine kinase |
| SD | Standard deviation |
| SRS | Stereotactic radiosurgery |
| SRT | Stereotactic radiation therapy |
| TKIs | Tyrosine kinase inhibitors |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.